
Therapeutic Advances in Psychopharmacology
@tapsychopharm
Leading gold Open Access journal delivering high-quality articles in psychopharmacology & related topics. Indexed in PubMed & Web of Science. Impact Factor 4.2.
ID: 1258337680674426880
http://journals.sagepub.com/home/tpp 07-05-2020 10:08:11
248 Tweet
491 Takipçi
357 Takip Edilen


New research online! Jim Van Os & Peter Groot from UMC Utrecht assess the outcomes of hyperbolic tapering of #antidepressants: journals.sagepub.com/doi/10.1177/20… #depression



New research online!📰 Here, Vivian Tsang, Brendan Tao and colleagues report on the safety and tolerability of intramuscular and sublingual ketamine in a #ketamine-assisted therapy program: journals.sagepub.com/doi/full/10.11… 🔓








New paper in Therapeutic Advances in Psychopharmacology with David Taylor & Mark Horowitz @markhoro.bsky.social Prolonging the interval between depot antipsychotics may allow potential for tapering. Peak rate of D2 occ change from abruptly stopping depots may explain withdrawal effects / symptom relapse journals.sagepub.com/doi/10.1177/20…

New research online! 🧠 Brandon Yarns and Carlson explore how aging-related changes, social factors, and emotional and psychological symptoms contribute to multiple health conditions in older adults. Read more below: 🔓bit.ly/48j005s #multimorbidity #aging #FOAMed

All the biases in psychedelic research very clearly laid out by Eiko Fried in Therapeutic Advances in Psychopharmacology. Well worth a read.



New paper!! Published by Therapeutic Advances in Psychopharmacology doi.org/10.1177/204512…
